Nanose Medical

About

Headcount over time

Offices

Q&A

What is Nanose Medical's primary focus?

Nanose Medical is an Israeli med-tech startup focused on pioneering non-invasive, breath-based diagnostics for the early detection of liver and lung cancer, utilizing AI-driven sensing technology.

When was Nanose Medical founded?

Nanose Medical was founded in October 2019.

What is the total amount of funding Nanose Medical has raised to date?

Nanose Medical has raised a total of $13,945,512 USD.

What was Nanose Medical's most recent funding round?

In May 2024, Nanose Medical received a Grant for $2,699,865 USD. Lead investors included Angel and Israel Innovation Authority

Which organizations have provided grant funding to Nanose Medical in 2024?

In January 2024, Nanose Medical received a Grant with lead investors Angel. They received another Grant in May 2024 from Angel, Israel Innovation Authority, and European Innovation Council.

What is the name of Nanose Medical's diagnostic device?

Nanose Medical's portable handheld device is called DiaNose, which analyzes exhaled breath VOCs.

What was a significant publication by Nanose Medical in January 2025?

In January 2025, Nanose Medical published a poster titled “Novel point-of-care, rapid breath test to identify patients with metabolic dysfunction associated steatotic liver disease with advanced fibrosis – a pilot study” at the EASL SLD Summit 2025.

What is the current employee count for Nanose Medical?

Nanose Medical has 1-10 employees.

Team · 9

Orit Marom-Albeck

Founder · Co-founder & CEO

Ilay Marom

Founder · Co-founder & COO

Osnat Sela Tavor

Founder · Co-founder & CSO

Prof. Hossam Haick

Founder · Inventor

Imad Telhami

Founder · Co-Founder & Board member

Prof. Yoram Weiss

Board Member

Dr. Omer Meroz

CTO

Gilad Feinberg

Software Eng Team Lead

Dana Nagler

Office Manager & HR Officer

Sectors & technology

Highlights

Tags